Metraipolis › archive › dc_5da35bb7a06c

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino… — Europe PMC PMID:41698311

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41698311
DOI
10.1016/j.vaccine.2026.128348
License (as archived)
solo-consultazione
Archived
2026-11-05T19:28:43.969Z
SHA-256 of the archived text
c0639b7542229084872c43775a7161a65b90ed8af3512a08dda9138309a5f5cc
Stable URL of this page
https://metraipolis.com/documento/dc_5da35bb7a06c

How to cite

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino… — Europe PMC PMID:41698311 — Europe PMC (en), https://europepmc.org/article/MED/41698311 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5da35bb7a06c (Metraipolis archive dc_5da35bb7a06c, sha256 c0639b7542229084872c43775a7161a65b90ed8af3512a08dda9138309a5f5cc)
BibTeX
@misc{dc5da35bb7a06c,
  title = {The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino… — Europe PMC PMID:41698311},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41698311},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5da35bb7a06c; sha256 c0639b7542229084872c43775a7161a65b90ed8af3512a08dda9138309a5f5cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41698311. Agents can read the archived copy with the MCP tool read_document.